Abstract:Spontaneous preterm birth (PTB) is a major obstetrical problem around the globe and the mechanisms leading to PTB are unclear. Recently, changes in the circulating levels of placental extracellular vesicles (EVs) during pregnancy have been associated with various pregnancy complications. However, progress in the field is hindered by the inability to isolate placental EVs from the maternal circulation. A longitudinal study design was used to determine the protein cargo present in circulating placental EVs in ma… Show more
“…Identification of miRNAs transported by EVs also revealed potential biomarkers for the prediction of pre-term birth [98]. Changes of the protein composition of circulating placental EVs could also be used for the identification of a high-risk status for pre-term birth across gestation [99]. Ninety-six proteins were expressed at significantly different levels, and a bioinformatics analysis revealed their connection to inflammatory pathways, epithelial mesenchymal transition, and coagulation/complement activation.…”
The ability of exosomes to transport different molecular cargoes and their ability to influence various physiological factors is already well known. An exciting area of research explores the functions of exosomes in healthy and pathological pregnancies. Placenta-derived exosomes were identified in the maternal circulation during pregnancy and their contribution in the crosstalk between mother and fetus are now starting to become defined. In this review, we will try to summarize actual knowledge about this topic and to answer the question of how important exosomes are for a healthy pregnancy.
“…Identification of miRNAs transported by EVs also revealed potential biomarkers for the prediction of pre-term birth [98]. Changes of the protein composition of circulating placental EVs could also be used for the identification of a high-risk status for pre-term birth across gestation [99]. Ninety-six proteins were expressed at significantly different levels, and a bioinformatics analysis revealed their connection to inflammatory pathways, epithelial mesenchymal transition, and coagulation/complement activation.…”
The ability of exosomes to transport different molecular cargoes and their ability to influence various physiological factors is already well known. An exciting area of research explores the functions of exosomes in healthy and pathological pregnancies. Placenta-derived exosomes were identified in the maternal circulation during pregnancy and their contribution in the crosstalk between mother and fetus are now starting to become defined. In this review, we will try to summarize actual knowledge about this topic and to answer the question of how important exosomes are for a healthy pregnancy.
“…In this regard, Menon and colleagues have analyzed placental EVs during pregnancy and at delivery, and found that samples at term associated a group of upregulated genes known to be regulators of epithelial mesenchymal transition (EMT). They hypothesized that, when approaching term, fetal components of the placenta undergo EMT, which leads to an increase in mesenchymal cells susceptible to oxidative stress followed by subsequent inflammation that precipitates delivery [ 112 , 113 ]. Moreover, as a response to increased oxidative stress, it has been demonstrated that phosphorylation of p38 mitogen-activated protein kinase (MAPK), an indicator of term parturition, takes place in amniotic epithelial cell (AEC)-derived exosomes [ 114 ].…”
Section: Extracellular Vesicles In Normal Pregnancymentioning
Extracellular vesicles (EVs) are small vesicles ranging from 20–200 nm to 10 μm in diameter that are discharged and taken in by many different types of cells. Depending on the nature and quantity of their content—which generally includes proteins, lipids as well as microRNAs (miRNAs), messenger-RNA (mRNA), and DNA—these particles can bring about functional modifications in the receiving cells. During pregnancy, placenta and/or fetal-derived EVs have recently been isolated, eliciting interest in discovering their clinical significance. To date, various studies have associated variations in the circulating levels of maternal and fetal EVs and their contents, with complications including gestational diabetes and preeclampsia, ultimately leading to adverse pregnancy outcomes. Furthermore, EVs have also been identified as messengers and important players in viral infections during pregnancy, as well as in various congenital malformations. Their presence can be detected in the maternal blood from the first trimester and their level increases towards term, thus acting as liquid biopsies that give invaluable insight into the status of the feto-placental unit. However, their exact roles in the metabolic and vascular adaptations associated with physiological and pathological pregnancy is still under investigation. Analyzing peer-reviewed journal articles available in online databases, the purpose of this review is to synthesize current knowledge regarding the utility of quantification of pregnancy related EVs in general and placental EVs in particular as non-invasive evidence of placental dysfunction and adverse pregnancy outcomes, and to develop the current understanding of these particles and their applicability in clinical practice.
“…Therefore, profiling their quantitative and intraexosomal cargoes may reflect conditional stress imposed on the placenta, and possibly on the fetus. In this context, several placental specific proteins have been studied, especially placental alkaline phosphatase (PLAP), syncytin-1, and syncytin-2 [1,[41][42][43][44][45][46][47]. These STEVs are released directly into the maternal circulation, where they may influence the surrounding tissue or may have systemic effects.…”
Attempts at predicting and diagnosing preeclampsia has so far been unsuccessful, with most studies investigating circulating free proteins or microRNAs. There is a need for improved noninvasive diagnosis and monitoring for preeclampsia outside the current clinical parameters. Such a biomarker would allow for preventative treatments to keep both the mother and fetus safe. It is well known that placental syncytiotrophoblasts at the maternal-fetal
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.